The vaccine was launched by the Gachibowli facility of Indian Immunologicals Limited (IIL) to treat bluetongue disease that affects lakhs of sheep, goats and cattle countrywide.
The vaccine has been launched with an aim to minimise the economic loss of the animal farming community due to the disease.
The development of the vaccine took a period of three years and is a result of the collaborations between IIL, TANUVAS (Tamil Nadu University of Veterinary and Animal Sciences) and ICAR (Indian Council of Agricultural Research).
The vaccine is priced at Rs 5 for the farmers and has been developed to protect the animals against five strains of the ‘bluetongue’ virus prevalent in the country.
India is one of the countries in the world that top animal diseases.
India has a population of 70 million sheep.